
    
      This is a multicenter, non-interventional, observation study designed to provide long-term
      safety and efficacy data on subjects who have participated in a prior Fate Therapeutics
      interventional study of FT500 cellular immunotherapy. Subjects will be contacted every six
      months (Â± one month), beginning six months after subject completion or withdrawal from the
      FT500-101 study.
    
  